Key contacts

General toolkit enquiries - Loth.RIDUguidelines@nhs.scot 

The key contact for this toolkit is Dr Callum Mutch, Specialty Registrar and the senior responsible owner is Dr Naomi Bulteel, Consultant Physician. Both can be contacted using the email address above.

 

Accessibility checks

Content has been checked for accessibility in line with the relevant RDS standard operating procedure.

 

Content management and governance

Clinical oversight and responsibility sits with the infectious diseases consultant group who meet each week. 

Additional content will be overseen by the Quality Improvement Team of RIDU which meets quarterly.

The infectious diseases department sits with the acute directorate of NHS Lothian. There are currently two governance structures in place - the Policy Oversight Group and the Drugs and Therapeutics Committee.

 

Content review

Each aspect of the toolkit is authored by a clinician and has been reviewed and signed off by the infectious diseases consultant group.

The guidelines group within the RIDU will monitor the generic email address and report to the RIDU Quality Improvement Team who will in turn oversee updates or any additional sections that are to be added to the toolkits.

 

Copyright

Copyright compliance for content has been checked and confirmed.

All icons are from Flaticon.com, accessed through the licence held Tactuum Ltd for the resources supported by the software platform it provides.

 

Evidence base

Authors have used the evidence available, either from guidelines or a review of available evidence.

 

Monitoring and acting on feedback and complaints

Emails for app enquiries or feedback are available in the "Key contacts" section above.

Any messages received through the RDS Feedback form will be forwarded by the RDS team to the key contact and generic email.

 

Risk assessment

The content has been risk assessed, and mitigations put in place where required.

 

User testing

The toolkit was reviewed and tested by key stakeholders between September and October 2024